Yomna Bedaiwy
Yomna Bedaiwy has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Avonae Gentles
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada; BC Women's Center for Pelvic Pain and Endometriosis Vancouver, BC, Canada
1 shared publication - Emma Goodwin
BC Women’s Center for Pelvic Pain and Endometriosis, Vancouver, BC V6H 3N1, Canada
1 shared publication - Nisha Marshall
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada
1 shared publication - Paul J. Yong
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada
1 shared publication
Latest Publications
- Open Access
- 10 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (24) , 7521
Nociplastic Pain in Endometriosis: A Scoping Review
Endometriosis is an inflammatory chronic condition associated with nociceptive, neuropathic, and nociplastic pain. Central sensitization (CS) is the primary nociplastic pain mechanism. However, there are currently no standardized methods for detecting CS or nociplastic pain. This review aims to identify available tools for characterizing CS/nociplastic pain in endometriosis-related chronic pelvic pain. Following the PRISMA-P protocol, MEDLINE, Embase, Scopus, and PsychINFO databases were searched on 23 April 2024, for the terms “endometriosis”, “central sensitization”, “nociplastic pain”, “widespread pain”, and “assessment tools”. Publications were selected if they mentioned tool(s) for detecting nociplastic pain or CS in endometriosis patients. Information was extracted on study demographics, assessment types, and the tools used for detection. Of the 379 citations retrieved, 30 papers met the inclusion criteria. When working to identify CS and nociplastic pain, fourteen studies exclusively used patient-reported questionnaires, six used quantitative sensory testing (QST), two used clinical assessments, and eight used multiple approaches combining patient-reported questionnaires and clinical assessment. This review illustrates the diversity of tools currently used to identify CS and nociplastic pain in endometriosis patients. Further research is needed to evaluate their validity and to standardize methods in order to improve the accuracy of nociplastic pain identification and guide treatment.
- 10 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (24) , 7521
Open AccessNociplastic Pain in Endometriosis: A Scoping Review
Endometriosis is an inflammatory chronic condition associated with nociceptive, neuropathic, and nociplastic pain. Central sensitization (CS) is the primary nociplastic pain mechanism. However, there are currently no standardized methods for detecting CS or nociplastic pain. This review aims to identify available tools for characterizing CS/nociplastic pain in endometriosis-related chronic pelvic pain. Following the PRISMA-P protocol, MEDLINE, Embase, Scopus, and PsychINFO databases were searched on 23 April 2024, for the terms “endometriosis”, “central sensitization”, “nociplastic pain”, “widespread pain”, and “assessment tools”. Publications were selected if they mentioned tool(s) for detecting nociplastic pain or CS in endometriosis patients. Information was extracted on study demographics, assessment types, and the tools used for detection. Of the 379 citations retrieved, 30 papers met the inclusion criteria. When working to identify CS and nociplastic pain, fourteen studies exclusively used patient-reported questionnaires, six used quantitative sensory testing (QST), two used clinical assessments, and eight used multiple approaches combining patient-reported questionnaires and clinical assessment. This review illustrates the diversity of tools currently used to identify CS and nociplastic pain in endometriosis patients. Further research is needed to evaluate their validity and to standardize methods in order to improve the accuracy of nociplastic pain identification and guide treatment.